Literature DB >> 17591509

Mental disorders among persons with heart disease - results from World Mental Health surveys.

Johan Ormel1, Michael Von Korff, Huibert Burger, Kate Scott, Koen Demyttenaere, Yue-qin Huang, José Posada-Villa, Jean Pierre Lepine, Matthias C Angermeyer, Daphna Levinson, Giovanni de Girolamo, Norito Kawakami, Elie Karam, María Elena Medina-Mora, Oye Gureje, David Williams, Josep Maria Haro, Evelyn J Bromet, Jordi Alonso, Ron Kessler.   

Abstract

OBJECTIVES: While depression and heart disease often co-occur in Western countries, less is known about the association of anxiety and alcohol use disorders with heart disease and about the cross-cultural consistency of this association. Consistency across emotional disorders and cultures would suggest that relatively universal mechanisms underlie the association.
METHODS: Surveys with 18 random population samples of household-residing adults in 17 countries in Europe, the Americas, the Middle East, Africa, Asia and the South Pacific were carried out. Medically recognized heart disease was ascertained by self-report. Mental disorders were assessed with the World Mental Health Composite International Diagnostic Interview, a fully structured diagnostic interview.
RESULTS: Specific mood and anxiety disorders occurred among persons with heart disease at rates higher than those among persons without heart disease. Adjusted for sex and age, the pooled odds ratios (95% confidence interval) were 2.1 (1.9-2.5) for mood disorders, 2.2 (1.9-2.5) for anxiety disorders and 1.4 (1.0-1.9) for alcohol abuse/dependence among persons with versus those without heart disease. These patterns were similar across countries.
CONCLUSIONS: An excess of anxiety disorders and that of mood disorders are found among persons with heart disease. These associations hold true across countries despite substantial between-country differences in culture and mental disorder prevalence rates. These results suggest that similar mechanisms underlie the association and that a broad spectrum of mood-anxiety disorders should be considered in research on the comorbidity of mental disorders and heart disease.

Entities:  

Mesh:

Year:  2007        PMID: 17591509      PMCID: PMC2048744          DOI: 10.1016/j.genhosppsych.2007.03.009

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  35 in total

1.  Depression as a risk factor for coronary heart disease mortality.

Authors:  R M Carney; K E Freedland; A S Jaffe
Journal:  Arch Gen Psychiatry       Date:  2001-03

2.  The US National Comorbidity Survey Replication (NCS-R): design and field procedures.

Authors:  Ronald C Kessler; Patricia Berglund; Wai Tat Chiu; Olga Demler; Steven Heeringa; Eva Hiripi; Robert Jin; Beth-Ellen Pennell; Ellen E Walters; Alan Zaslavsky; Hui Zheng
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

3.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

4.  Predicting medically unexplained physical symptoms and health care utilization. A symptom-perception approach.

Authors:  A M M Kolk; G J F P Hanewald; S Schagen; C M T Gijsbers van Wijk
Journal:  J Psychosom Res       Date:  2002-01       Impact factor: 3.006

5.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

6.  Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county.

Authors:  S Tretli; P G Lund-Larsen; O P Foss
Journal:  J Epidemiol Community Health       Date:  1982-12       Impact factor: 3.710

7.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

Authors:  S Yusuf; S Reddy; S Ounpuu; S Anand
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

8.  Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.

Authors:  J J Strik; A Honig; R Lousberg; A H Lousberg; E C Cheriex; H G Tuynman-Qua; P M Kuijpers; H J Wellens; H M Van Praag
Journal:  Psychosom Med       Date:  2000 Nov-Dec       Impact factor: 4.312

Review 9.  Epidemiology of comorbid coronary artery disease and depression.

Authors:  Bruce Rudisch; Charles B Nemeroff
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

Review 10.  Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.

Authors:  Heather S Lett; James A Blumenthal; Michael A Babyak; Andrew Sherwood; Timothy Strauman; Clive Robins; Mark F Newman
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

View more
  34 in total

1.  Mental health and the global agenda: core conceptual issues.

Authors:  Rachel Jenkins; Florence Baingana; Raheelah Ahmad; David McDaid; Rifat Atun
Journal:  Ment Health Fam Med       Date:  2011-06

2.  Associations between DSM-IV mental disorders and subsequent heart disease onset: beyond depression.

Authors:  Kate M Scott; Peter de Jonge; Jordi Alonso; Maria Carmen Viana; Zhaorui Liu; Siobhan O'Neill; Sergio Aguilar-Gaxiola; Ronny Bruffaerts; Jose Miguel Caldas-de-Almeida; Dan J Stein; Giovanni de Girolamo; Silvia E Florescu; Chiyi Hu; Nezar Ismet Taib; Jean-Pierre Lépine; Daphna Levinson; Herbert Matschinger; Maria Elena Medina-Mora; Marina Piazza; José A Posada-Villa; Hidenori Uda; Bogdan J Wojtyniak; Carmen C W Lim; Ronald C Kessler
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

Review 3.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

4.  The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample.

Authors:  Jess G Fiedorowicz; Jianping He; Kathleen R Merikangas
Journal:  J Psychosom Res       Date:  2010-09-18       Impact factor: 3.006

5.  Gender differences in age of smoking initiation and its association with health.

Authors:  Azure B Thompson; Jacob K Tebes; Sherry A McKee
Journal:  Addict Res Theory       Date:  2015-04-27

Review 6.  Depression in Cardiovascular Patients in Middle Eastern Populations: A Literature Review.

Authors:  Tam Truong Donnelly; Jassim Mohd Al Suwaidi; Awad Al-Qahtani; Nidal Asaad; Najlaa Abdul Qader; Rajvir Singh; Tak Shing Fung; Irem Mueed; Shima Sharara; Noha El Banna; Sarah Omar
Journal:  J Immigr Minor Health       Date:  2015-08

7.  An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective.

Authors:  Rhonda BeLue; Titilayo A Okoror; Juliet Iwelunmor; Kelly D Taylor; Arnold N Degboe; Charles Agyemang; Gbenga Ogedegbe
Journal:  Global Health       Date:  2009-09-22       Impact factor: 4.185

8.  The association between panic disorder and coronary artery disease among primary care patients presenting with chest pain: an updated literature review.

Authors:  David A Katerndahl
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

9.  Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease.

Authors:  Lynn V Doering; Debra K Moser; Barbara Riegel; Sharon McKinley; Patricia Davidson; Heather Baker; Hendrika Meischke; Kathleen Dracup
Journal:  Int J Cardiol       Date:  2009-06-02       Impact factor: 4.164

Review 10.  Metabolomics Biomarkers for Precision Psychiatry.

Authors:  Pei-An Betty Shih
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.